Emo Capital Corp. (NUVI) Stock Competitors & Peer Comparison
See (NUVI) competitors and their performances in Stock Market.
Peer Comparison Table: Household & Personal Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NUVI | $4.00 | +0.00% | 1.8M | 33.33 | $0.12 | N/A |
| LRLCY | $87.25 | +0.80% | 232.7B | 32.78 | $2.66 | +1.93% |
| LRLCF | $430.04 | +0.15% | 229B | 32.41 | $13.27 | +1.96% |
| UNLYF | $55.61 | +0.02% | 120.4B | 18.47 | $3.01 | +4.00% |
| RBGLY | $12.26 | -0.16% | 39.6B | 9.36 | $1.31 | +9.82% |
| RBGPF | $58.67 | -3.12% | 37.3B | 8.94 | $6.56 | +10.67% |
| HENOY | $19.19 | -0.31% | 31.8B | 13.43 | $1.43 | +3.16% |
| HENOF | $74.64 | -3.90% | 30.9B | 13.07 | $5.71 | +3.24% |
| HENKY | $17.95 | -0.44% | 29.8B | 12.55 | $1.43 | +3.34% |
| HELKF | $69.35 | -6.57% | 28.7B | 12.15 | $5.71 | +3.46% |
Stock Comparison
NUVI vs LRLCY Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, LRLCY has a market cap of 232.7B. Regarding current trading prices, NUVI is priced at $4.00, while LRLCY trades at $87.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas LRLCY's P/E ratio is 32.78. In terms of profitability, NUVI's ROE is +0.01%, compared to LRLCY's ROE of +0.18%. Regarding short-term risk, NUVI is more volatile compared to LRLCY. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check LRLCY's competition here
NUVI vs LRLCF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, LRLCF has a market cap of 229B. Regarding current trading prices, NUVI is priced at $4.00, while LRLCF trades at $430.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas LRLCF's P/E ratio is 32.41. In terms of profitability, NUVI's ROE is +0.01%, compared to LRLCF's ROE of +0.19%. Regarding short-term risk, NUVI is more volatile compared to LRLCF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check LRLCF's competition here
NUVI vs UNLYF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, UNLYF has a market cap of 120.4B. Regarding current trading prices, NUVI is priced at $4.00, while UNLYF trades at $55.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas UNLYF's P/E ratio is 18.47. In terms of profitability, NUVI's ROE is +0.01%, compared to UNLYF's ROE of +0.37%. Regarding short-term risk, NUVI is more volatile compared to UNLYF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check UNLYF's competition here
NUVI vs RBGLY Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, RBGLY has a market cap of 39.6B. Regarding current trading prices, NUVI is priced at $4.00, while RBGLY trades at $12.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas RBGLY's P/E ratio is 9.36. In terms of profitability, NUVI's ROE is +0.01%, compared to RBGLY's ROE of +0.45%. Regarding short-term risk, NUVI is more volatile compared to RBGLY. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check RBGLY's competition here
NUVI vs RBGPF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, RBGPF has a market cap of 37.3B. Regarding current trading prices, NUVI is priced at $4.00, while RBGPF trades at $58.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas RBGPF's P/E ratio is 8.94. In terms of profitability, NUVI's ROE is +0.01%, compared to RBGPF's ROE of +0.45%. Regarding short-term risk, NUVI is more volatile compared to RBGPF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check RBGPF's competition here
NUVI vs HENOY Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, HENOY has a market cap of 31.8B. Regarding current trading prices, NUVI is priced at $4.00, while HENOY trades at $19.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas HENOY's P/E ratio is 13.43. In terms of profitability, NUVI's ROE is +0.01%, compared to HENOY's ROE of +0.10%. Regarding short-term risk, NUVI is more volatile compared to HENOY. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check HENOY's competition here
NUVI vs HENOF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, HENOF has a market cap of 30.9B. Regarding current trading prices, NUVI is priced at $4.00, while HENOF trades at $74.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas HENOF's P/E ratio is 13.07. In terms of profitability, NUVI's ROE is +0.01%, compared to HENOF's ROE of +0.10%. Regarding short-term risk, NUVI is more volatile compared to HENOF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check HENOF's competition here
NUVI vs HENKY Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, HENKY has a market cap of 29.8B. Regarding current trading prices, NUVI is priced at $4.00, while HENKY trades at $17.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas HENKY's P/E ratio is 12.55. In terms of profitability, NUVI's ROE is +0.01%, compared to HENKY's ROE of +0.10%. Regarding short-term risk, NUVI is more volatile compared to HENKY. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check HENKY's competition here
NUVI vs HELKF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, HELKF has a market cap of 28.7B. Regarding current trading prices, NUVI is priced at $4.00, while HELKF trades at $69.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas HELKF's P/E ratio is 12.15. In terms of profitability, NUVI's ROE is +0.01%, compared to HELKF's ROE of +0.10%. Regarding short-term risk, NUVI is more volatile compared to HELKF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check HELKF's competition here
NUVI vs ETTYF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, ETTYF has a market cap of 18.7B. Regarding current trading prices, NUVI is priced at $4.00, while ETTYF trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas ETTYF's P/E ratio is 14.25. In terms of profitability, NUVI's ROE is +0.01%, compared to ETTYF's ROE of +0.15%. Regarding short-term risk, NUVI is more volatile compared to ETTYF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check ETTYF's competition here
NUVI vs BDRFF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, BDRFF has a market cap of 17.4B. Regarding current trading prices, NUVI is priced at $4.00, while BDRFF trades at $79.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas BDRFF's P/E ratio is 16.18. In terms of profitability, NUVI's ROE is +0.01%, compared to BDRFF's ROE of +0.11%. Regarding short-term risk, NUVI is more volatile compared to BDRFF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check BDRFF's competition here
NUVI vs BDRFY Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, BDRFY has a market cap of 17.3B. Regarding current trading prices, NUVI is priced at $4.00, while BDRFY trades at $15.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas BDRFY's P/E ratio is 16.01. In terms of profitability, NUVI's ROE is +0.01%, compared to BDRFY's ROE of +0.11%. Regarding short-term risk, NUVI is more volatile compared to BDRFY. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check BDRFY's competition here
NUVI vs KAOOY Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, KAOOY has a market cap of 16.9B. Regarding current trading prices, NUVI is priced at $4.00, while KAOOY trades at $7.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas KAOOY's P/E ratio is 25.77. In terms of profitability, NUVI's ROE is +0.01%, compared to KAOOY's ROE of +0.13%. Regarding short-term risk, NUVI is more volatile compared to KAOOY. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check KAOOY's competition here
NUVI vs KAOCF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, KAOCF has a market cap of 15.9B. Regarding current trading prices, NUVI is priced at $4.00, while KAOCF trades at $35.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas KAOCF's P/E ratio is 24.19. In terms of profitability, NUVI's ROE is +0.01%, compared to KAOCF's ROE of +0.12%. Regarding short-term risk, NUVI is more volatile compared to KAOCF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check KAOCF's competition here
NUVI vs UNCHF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, UNCHF has a market cap of 10.3B. Regarding current trading prices, NUVI is priced at $4.00, while UNCHF trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas UNCHF's P/E ratio is 27.27. In terms of profitability, NUVI's ROE is +0.01%, compared to UNCHF's ROE of +0.08%. Regarding short-term risk, NUVI is more volatile compared to UNCHF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check UNCHF's competition here
NUVI vs UNICY Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, UNICY has a market cap of 9.9B. Regarding current trading prices, NUVI is priced at $4.00, while UNICY trades at $2.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas UNICY's P/E ratio is 26.04. In terms of profitability, NUVI's ROE is +0.01%, compared to UNICY's ROE of +0.08%. Regarding short-term risk, NUVI is more volatile compared to UNICY. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check UNICY's competition here
NUVI vs SSDOF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, SSDOF has a market cap of 7.6B. Regarding current trading prices, NUVI is priced at $4.00, while SSDOF trades at $19.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas SSDOF's P/E ratio is -29.84. In terms of profitability, NUVI's ROE is +0.01%, compared to SSDOF's ROE of -0.06%. Regarding short-term risk, NUVI is more volatile compared to SSDOF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check SSDOF's competition here
NUVI vs SSDOY Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, SSDOY has a market cap of 6.6B. Regarding current trading prices, NUVI is priced at $4.00, while SSDOY trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas SSDOY's P/E ratio is -25.67. In terms of profitability, NUVI's ROE is +0.01%, compared to SSDOY's ROE of -0.06%. Regarding short-term risk, NUVI is more volatile compared to SSDOY. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check SSDOY's competition here
NUVI vs LCCTF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, LCCTF has a market cap of 6.6B. Regarding current trading prices, NUVI is priced at $4.00, while LCCTF trades at $4.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas LCCTF's P/E ratio is 63.57. In terms of profitability, NUVI's ROE is +0.01%, compared to LCCTF's ROE of +0.09%. Regarding short-term risk, NUVI is more volatile compared to LCCTF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check LCCTF's competition here
NUVI vs KCDMF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, KCDMF has a market cap of 6.5B. Regarding current trading prices, NUVI is priced at $4.00, while KCDMF trades at $2.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas KCDMF's P/E ratio is 14.53. In terms of profitability, NUVI's ROE is +0.01%, compared to KCDMF's ROE of +1.61%. Regarding short-term risk, NUVI is more volatile compared to KCDMF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check KCDMF's competition here
NUVI vs KCDMY Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, KCDMY has a market cap of 6.4B. Regarding current trading prices, NUVI is priced at $4.00, while KCDMY trades at $10.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas KCDMY's P/E ratio is 14.16. In terms of profitability, NUVI's ROE is +0.01%, compared to KCDMY's ROE of +1.61%. Regarding short-term risk, NUVI is more volatile compared to KCDMY. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check KCDMY's competition here
NUVI vs BICEY Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, BICEY has a market cap of 5.3B. Regarding current trading prices, NUVI is priced at $4.00, while BICEY trades at $31.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas BICEY's P/E ratio is 26.69. In terms of profitability, NUVI's ROE is +0.01%, compared to BICEY's ROE of +0.05%. Regarding short-term risk, NUVI is more volatile compared to BICEY. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check BICEY's competition here
NUVI vs NTCOY Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, NTCOY has a market cap of 3.8B. Regarding current trading prices, NUVI is priced at $4.00, while NTCOY trades at $5.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas NTCOY's P/E ratio is -8.30. In terms of profitability, NUVI's ROE is +0.01%, compared to NTCOY's ROE of -0.15%. Regarding short-term risk, NUVI is more volatile compared to NTCOY. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check NTCOY's competition here
NUVI vs HEGIF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, HEGIF has a market cap of 3.7B. Regarding current trading prices, NUVI is priced at $4.00, while HEGIF trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas HEGIF's P/E ratio is 11.03. In terms of profitability, NUVI's ROE is +0.01%, compared to HEGIF's ROE of +0.12%. Regarding short-term risk, NUVI is more volatile compared to HEGIF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check HEGIF's competition here
NUVI vs VDAHF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, VDAHF has a market cap of 3.6B. Regarding current trading prices, NUVI is priced at $4.00, while VDAHF trades at $2.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas VDAHF's P/E ratio is 99.00. In terms of profitability, NUVI's ROE is +0.01%, compared to VDAHF's ROE of +0.02%. Regarding short-term risk, NUVI is more volatile compared to VDAHF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check VDAHF's competition here
NUVI vs HEGIY Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, HEGIY has a market cap of 3.6B. Regarding current trading prices, NUVI is priced at $4.00, while HEGIY trades at $15.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas HEGIY's P/E ratio is 9.45. In terms of profitability, NUVI's ROE is +0.01%, compared to HEGIY's ROE of +0.08%. Regarding short-term risk, NUVI is more volatile compared to HEGIY. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check HEGIY's competition here
NUVI vs RPHCF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, RPHCF has a market cap of 3.4B. Regarding current trading prices, NUVI is priced at $4.00, while RPHCF trades at $15.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas RPHCF's P/E ratio is 16.70. In terms of profitability, NUVI's ROE is +0.01%, compared to RPHCF's ROE of +0.12%. Regarding short-term risk, NUVI is more volatile compared to RPHCF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check RPHCF's competition here
NUVI vs UNLRY Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, UNLRY has a market cap of 3.3B. Regarding current trading prices, NUVI is priced at $4.00, while UNLRY trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas UNLRY's P/E ratio is 15.73. In terms of profitability, NUVI's ROE is +0.01%, compared to UNLRY's ROE of +1.82%. Regarding short-term risk, NUVI is more volatile compared to UNLRY. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check UNLRY's competition here
NUVI vs LIOPF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, LIOPF has a market cap of 3.2B. Regarding current trading prices, NUVI is priced at $4.00, while LIOPF trades at $11.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas LIOPF's P/E ratio is 18.27. In terms of profitability, NUVI's ROE is +0.01%, compared to LIOPF's ROE of +0.09%. Regarding short-term risk, NUVI is more volatile compared to LIOPF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check LIOPF's competition here
NUVI vs VDAHY Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, VDAHY has a market cap of 3B. Regarding current trading prices, NUVI is priced at $4.00, while VDAHY trades at $21.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas VDAHY's P/E ratio is 108.35. In terms of profitability, NUVI's ROE is +0.01%, compared to VDAHY's ROE of +0.02%. Regarding short-term risk, NUVI is more volatile compared to VDAHY. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check VDAHY's competition here
NUVI vs UNLRF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, UNLRF has a market cap of 2.8B. Regarding current trading prices, NUVI is priced at $4.00, while UNLRF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas UNLRF's P/E ratio is 7.44. In terms of profitability, NUVI's ROE is +0.01%, compared to UNLRF's ROE of +1.81%. Regarding short-term risk, NUVI is more volatile compared to UNLRF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check UNLRF's competition here
NUVI vs BICEF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, BICEF has a market cap of 2.8B. Regarding current trading prices, NUVI is priced at $4.00, while BICEF trades at $68.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas BICEF's P/E ratio is 28.12. In terms of profitability, NUVI's ROE is +0.01%, compared to BICEF's ROE of +0.05%. Regarding short-term risk, NUVI is more volatile compared to BICEF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check BICEF's competition here
NUVI vs LIOPY Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, LIOPY has a market cap of 2.7B. Regarding current trading prices, NUVI is priced at $4.00, while LIOPY trades at $19.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas LIOPY's P/E ratio is 26.49. In terms of profitability, NUVI's ROE is +0.01%, compared to LIOPY's ROE of +0.09%. Regarding short-term risk, NUVI is more volatile compared to LIOPY. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check LIOPY's competition here
NUVI vs KBYPF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, KBYPF has a market cap of 2.5B. Regarding current trading prices, NUVI is priced at $4.00, while KBYPF trades at $34.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas KBYPF's P/E ratio is 109.84. In terms of profitability, NUVI's ROE is +0.01%, compared to KBYPF's ROE of +0.01%. Regarding short-term risk, NUVI is more volatile compared to KBYPF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check KBYPF's competition here
NUVI vs FACYF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, FACYF has a market cap of 2.4B. Regarding current trading prices, NUVI is priced at $4.00, while FACYF trades at $17.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas FACYF's P/E ratio is 34.22. In terms of profitability, NUVI's ROE is +0.01%, compared to FACYF's ROE of +0.22%. Regarding short-term risk, NUVI is more volatile compared to FACYF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check FACYF's competition here
NUVI vs BLUMY Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, BLUMY has a market cap of 2.2B. Regarding current trading prices, NUVI is priced at $4.00, while BLUMY trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas BLUMY's P/E ratio is -50.00. In terms of profitability, NUVI's ROE is +0.01%, compared to BLUMY's ROE of -0.04%. Regarding short-term risk, NUVI is more volatile compared to BLUMY. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check BLUMY's competition here
NUVI vs PORBF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, PORBF has a market cap of 1.9B. Regarding current trading prices, NUVI is priced at $4.00, while PORBF trades at $8.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas PORBF's P/E ratio is 45.79. In terms of profitability, NUVI's ROE is +0.01%, compared to PORBF's ROE of +0.07%. Regarding short-term risk, NUVI is more volatile compared to PORBF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check PORBF's competition here
NUVI vs KOSCF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, KOSCF has a market cap of 1.9B. Regarding current trading prices, NUVI is priced at $4.00, while KOSCF trades at $33.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas KOSCF's P/E ratio is 19.88. In terms of profitability, NUVI's ROE is +0.01%, compared to KOSCF's ROE of +0.03%. Regarding short-term risk, NUVI is more volatile compared to KOSCF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check KOSCF's competition here
NUVI vs KSRYY Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, KSRYY has a market cap of 1.9B. Regarding current trading prices, NUVI is priced at $4.00, while KSRYY trades at $6.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas KSRYY's P/E ratio is 19.79. In terms of profitability, NUVI's ROE is +0.01%, compared to KSRYY's ROE of +0.03%. Regarding short-term risk, NUVI is more volatile compared to KSRYY. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check KSRYY's competition here
NUVI vs MIOFF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, MIOFF has a market cap of 1.7B. Regarding current trading prices, NUVI is priced at $4.00, while MIOFF trades at $52.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas MIOFF's P/E ratio is 40.46. In terms of profitability, NUVI's ROE is +0.01%, compared to MIOFF's ROE of +0.04%. Regarding short-term risk, NUVI is more volatile compared to MIOFF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check MIOFF's competition here
NUVI vs PGENY Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, PGENY has a market cap of 1.3B. Regarding current trading prices, NUVI is priced at $4.00, while PGENY trades at $2.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas PGENY's P/E ratio is 25.27. In terms of profitability, NUVI's ROE is +0.01%, compared to PGENY's ROE of +0.11%. Regarding short-term risk, NUVI is more volatile compared to PGENY. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check PGENY's competition here
NUVI vs PIGEF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, PIGEF has a market cap of 1.2B. Regarding current trading prices, NUVI is priced at $4.00, while PIGEF trades at $10.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas PIGEF's P/E ratio is 22.93. In terms of profitability, NUVI's ROE is +0.01%, compared to PIGEF's ROE of +0.11%. Regarding short-term risk, NUVI is more volatile compared to PIGEF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check PIGEF's competition here
NUVI vs SRTSF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, SRTSF has a market cap of 1B. Regarding current trading prices, NUVI is priced at $4.00, while SRTSF trades at $16.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas SRTSF's P/E ratio is 17.29. In terms of profitability, NUVI's ROE is +0.01%, compared to SRTSF's ROE of +0.14%. Regarding short-term risk, NUVI is more volatile compared to SRTSF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check SRTSF's competition here
NUVI vs ONXYY Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, ONXYY has a market cap of 800M. Regarding current trading prices, NUVI is priced at $4.00, while ONXYY trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas ONXYY's P/E ratio is 20.83. In terms of profitability, NUVI's ROE is +0.01%, compared to ONXYY's ROE of -0.18%. Regarding short-term risk, NUVI is more volatile compared to ONXYY. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check ONXYY's competition here
NUVI vs MDOMF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, MDOMF has a market cap of 722.2M. Regarding current trading prices, NUVI is priced at $4.00, while MDOMF trades at $16.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas MDOMF's P/E ratio is 57.14. In terms of profitability, NUVI's ROE is +0.01%, compared to MDOMF's ROE of +0.03%. Regarding short-term risk, NUVI is more volatile compared to MDOMF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check MDOMF's competition here
NUVI vs ZNZNF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, ZNZNF has a market cap of 567M. Regarding current trading prices, NUVI is priced at $4.00, while ZNZNF trades at $14.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas ZNZNF's P/E ratio is 13.89. In terms of profitability, NUVI's ROE is +0.01%, compared to ZNZNF's ROE of +0.34%. Regarding short-term risk, NUVI is more volatile compared to ZNZNF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check ZNZNF's competition here
NUVI vs DUNIY Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, DUNIY has a market cap of 471.4M. Regarding current trading prices, NUVI is priced at $4.00, while DUNIY trades at $10.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas DUNIY's P/E ratio is N/A. In terms of profitability, NUVI's ROE is +0.01%, compared to DUNIY's ROE of +0.08%. Regarding short-term risk, NUVI is more volatile compared to DUNIY. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check DUNIY's competition here
NUVI vs YAMNF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, YAMNF has a market cap of 464.9M. Regarding current trading prices, NUVI is priced at $4.00, while YAMNF trades at $8.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas YAMNF's P/E ratio is 8.37. In terms of profitability, NUVI's ROE is +0.01%, compared to YAMNF's ROE of -0.02%. Regarding short-term risk, NUVI is more volatile compared to YAMNF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check YAMNF's competition here
NUVI vs PZCUY Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, PZCUY has a market cap of 375.4M. Regarding current trading prices, NUVI is priced at $4.00, while PZCUY trades at $1.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas PZCUY's P/E ratio is -44.75. In terms of profitability, NUVI's ROE is +0.01%, compared to PZCUY's ROE of -0.02%. Regarding short-term risk, NUVI is more volatile compared to PZCUY. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check PZCUY's competition here
NUVI vs ONXXF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, ONXXF has a market cap of 318.9M. Regarding current trading prices, NUVI is priced at $4.00, while ONXXF trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas ONXXF's P/E ratio is 17.39. In terms of profitability, NUVI's ROE is +0.01%, compared to ONXXF's ROE of -0.18%. Regarding short-term risk, NUVI is more volatile compared to ONXXF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check ONXXF's competition here
NUVI vs MCBRF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, MCBRF has a market cap of 314.4M. Regarding current trading prices, NUVI is priced at $4.00, while MCBRF trades at $1.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas MCBRF's P/E ratio is 8.00. In terms of profitability, NUVI's ROE is +0.01%, compared to MCBRF's ROE of +0.31%. Regarding short-term risk, NUVI is more volatile compared to MCBRF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check MCBRF's competition here
NUVI vs WPNTF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, WPNTF has a market cap of 232.7M. Regarding current trading prices, NUVI is priced at $4.00, while WPNTF trades at $2.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas WPNTF's P/E ratio is 12.00. In terms of profitability, NUVI's ROE is +0.01%, compared to WPNTF's ROE of +0.19%. Regarding short-term risk, NUVI is more volatile compared to WPNTF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check WPNTF's competition here
NUVI vs KITAF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, KITAF has a market cap of 130.9M. Regarding current trading prices, NUVI is priced at $4.00, while KITAF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas KITAF's P/E ratio is 18.77. In terms of profitability, NUVI's ROE is +0.01%, compared to KITAF's ROE of +0.09%. Regarding short-term risk, NUVI is more volatile compared to KITAF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check KITAF's competition here
NUVI vs OLVI Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, OLVI has a market cap of 122.3M. Regarding current trading prices, NUVI is priced at $4.00, while OLVI trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas OLVI's P/E ratio is N/A. In terms of profitability, NUVI's ROE is +0.01%, compared to OLVI's ROE of -0.82%. Regarding short-term risk, NUVI is more volatile compared to OLVI. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check OLVI's competition here
NUVI vs NBBTF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, NBBTF has a market cap of 122.1M. Regarding current trading prices, NUVI is priced at $4.00, while NBBTF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas NBBTF's P/E ratio is -6.10. In terms of profitability, NUVI's ROE is +0.01%, compared to NBBTF's ROE of +0.02%. Regarding short-term risk, NUVI is more volatile compared to NBBTF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check NBBTF's competition here
NUVI vs PRFUF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, PRFUF has a market cap of 105.8M. Regarding current trading prices, NUVI is priced at $4.00, while PRFUF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas PRFUF's P/E ratio is -4.80. In terms of profitability, NUVI's ROE is +0.01%, compared to PRFUF's ROE of -0.04%. Regarding short-term risk, NUVI is more volatile compared to PRFUF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check PRFUF's competition here
NUVI vs UNHLF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, UNHLF has a market cap of 101.1M. Regarding current trading prices, NUVI is priced at $4.00, while UNHLF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas UNHLF's P/E ratio is -4.30. In terms of profitability, NUVI's ROE is +0.01%, compared to UNHLF's ROE of -0.11%. Regarding short-term risk, NUVI is more volatile compared to UNHLF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check UNHLF's competition here
NUVI vs KPTSF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, KPTSF has a market cap of 95M. Regarding current trading prices, NUVI is priced at $4.00, while KPTSF trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas KPTSF's P/E ratio is 14.58. In terms of profitability, NUVI's ROE is +0.01%, compared to KPTSF's ROE of +0.06%. Regarding short-term risk, NUVI is more volatile compared to KPTSF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check KPTSF's competition here
NUVI vs RVIV Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, RVIV has a market cap of 79M. Regarding current trading prices, NUVI is priced at $4.00, while RVIV trades at $13.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas RVIV's P/E ratio is 64.29. In terms of profitability, NUVI's ROE is +0.01%, compared to RVIV's ROE of -0.02%. Regarding short-term risk, NUVI is more volatile compared to RVIV. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check RVIV's competition here
NUVI vs ADTI Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, ADTI has a market cap of 25.3M. Regarding current trading prices, NUVI is priced at $4.00, while ADTI trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas ADTI's P/E ratio is -2.75. In terms of profitability, NUVI's ROE is +0.01%, compared to ADTI's ROE of +0.72%. Regarding short-term risk, NUVI is more volatile compared to ADTI. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check ADTI's competition here
NUVI vs DQWS Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, DQWS has a market cap of 8.8M. Regarding current trading prices, NUVI is priced at $4.00, while DQWS trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas DQWS's P/E ratio is N/A. In terms of profitability, NUVI's ROE is +0.01%, compared to DQWS's ROE of -2.20%. Regarding short-term risk, NUVI is more volatile compared to DQWS. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check DQWS's competition here
NUVI vs PURE Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, PURE has a market cap of 7.3M. Regarding current trading prices, NUVI is priced at $4.00, while PURE trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas PURE's P/E ratio is -3.27. In terms of profitability, NUVI's ROE is +0.01%, compared to PURE's ROE of +0.40%. Regarding short-term risk, NUVI is more volatile compared to PURE. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check PURE's competition here
NUVI vs MIMNF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, MIMNF has a market cap of 6.8M. Regarding current trading prices, NUVI is priced at $4.00, while MIMNF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas MIMNF's P/E ratio is 17.10. In terms of profitability, NUVI's ROE is +0.01%, compared to MIMNF's ROE of N/A. Regarding short-term risk, NUVI is more volatile compared to MIMNF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check MIMNF's competition here
NUVI vs MAVBF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, MAVBF has a market cap of 4.8M. Regarding current trading prices, NUVI is priced at $4.00, while MAVBF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas MAVBF's P/E ratio is -0.03. In terms of profitability, NUVI's ROE is +0.01%, compared to MAVBF's ROE of -2.47%. Regarding short-term risk, NUVI is more volatile compared to MAVBF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check MAVBF's competition here
NUVI vs NASO Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, NASO has a market cap of 4.4M. Regarding current trading prices, NUVI is priced at $4.00, while NASO trades at $1.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas NASO's P/E ratio is -3.60. In terms of profitability, NUVI's ROE is +0.01%, compared to NASO's ROE of +0.46%. Regarding short-term risk, NUVI is more volatile compared to NASO. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check NASO's competition here
NUVI vs CLGOF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, CLGOF has a market cap of 4M. Regarding current trading prices, NUVI is priced at $4.00, while CLGOF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas CLGOF's P/E ratio is -2.94. In terms of profitability, NUVI's ROE is +0.01%, compared to CLGOF's ROE of +1.43%. Regarding short-term risk, NUVI is more volatile compared to CLGOF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check CLGOF's competition here
NUVI vs REVRQ Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, REVRQ has a market cap of 3.8M. Regarding current trading prices, NUVI is priced at $4.00, while REVRQ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas REVRQ's P/E ratio is -0.01. In terms of profitability, NUVI's ROE is +0.01%, compared to REVRQ's ROE of +0.29%. Regarding short-term risk, NUVI is more volatile compared to REVRQ. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check REVRQ's competition here
NUVI vs CAWW Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, CAWW has a market cap of 3.4M. Regarding current trading prices, NUVI is priced at $4.00, while CAWW trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas CAWW's P/E ratio is 22.50. In terms of profitability, NUVI's ROE is +0.01%, compared to CAWW's ROE of +0.03%. Regarding short-term risk, NUVI is more volatile compared to CAWW. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check CAWW's competition here
NUVI vs ZOONF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, ZOONF has a market cap of 1.2M. Regarding current trading prices, NUVI is priced at $4.00, while ZOONF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas ZOONF's P/E ratio is -0.30. In terms of profitability, NUVI's ROE is +0.01%, compared to ZOONF's ROE of -1.08%. Regarding short-term risk, NUVI is more volatile compared to ZOONF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check ZOONF's competition here
NUVI vs SKVI Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, SKVI has a market cap of 1.1M. Regarding current trading prices, NUVI is priced at $4.00, while SKVI trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas SKVI's P/E ratio is -1.00. In terms of profitability, NUVI's ROE is +0.01%, compared to SKVI's ROE of +0.10%. Regarding short-term risk, NUVI is more volatile compared to SKVI. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check SKVI's competition here
NUVI vs SLGD Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, SLGD has a market cap of 812.9K. Regarding current trading prices, NUVI is priced at $4.00, while SLGD trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas SLGD's P/E ratio is -0.19. In terms of profitability, NUVI's ROE is +0.01%, compared to SLGD's ROE of +0.35%. Regarding short-term risk, NUVI is more volatile compared to SLGD. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check SLGD's competition here
NUVI vs SPCO Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, SPCO has a market cap of 777K. Regarding current trading prices, NUVI is priced at $4.00, while SPCO trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas SPCO's P/E ratio is -19.19. In terms of profitability, NUVI's ROE is +0.01%, compared to SPCO's ROE of -0.01%. Regarding short-term risk, NUVI is more volatile compared to SPCO. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check SPCO's competition here
NUVI vs PYCT Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, PYCT has a market cap of 553.7K. Regarding current trading prices, NUVI is priced at $4.00, while PYCT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas PYCT's P/E ratio is N/A. In terms of profitability, NUVI's ROE is +0.01%, compared to PYCT's ROE of +0.64%. Regarding short-term risk, NUVI is more volatile compared to PYCT. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check PYCT's competition here
NUVI vs PHLI Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, PHLI has a market cap of 438.3K. Regarding current trading prices, NUVI is priced at $4.00, while PHLI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas PHLI's P/E ratio is N/A. In terms of profitability, NUVI's ROE is +0.01%, compared to PHLI's ROE of -0.54%. Regarding short-term risk, NUVI is more volatile compared to PHLI. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check PHLI's competition here
NUVI vs SNST Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, SNST has a market cap of 265.9K. Regarding current trading prices, NUVI is priced at $4.00, while SNST trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas SNST's P/E ratio is -0.03. In terms of profitability, NUVI's ROE is +0.01%, compared to SNST's ROE of -1.59%. Regarding short-term risk, NUVI is more volatile compared to SNST. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check SNST's competition here
NUVI vs SNBH Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, SNBH has a market cap of 181.9K. Regarding current trading prices, NUVI is priced at $4.00, while SNBH trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas SNBH's P/E ratio is -0.23. In terms of profitability, NUVI's ROE is +0.01%, compared to SNBH's ROE of +0.39%. Regarding short-term risk, NUVI is more volatile compared to SNBH. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check SNBH's competition here
NUVI vs HRSR Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, HRSR has a market cap of 177.6K. Regarding current trading prices, NUVI is priced at $4.00, while HRSR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas HRSR's P/E ratio is -0.02. In terms of profitability, NUVI's ROE is +0.01%, compared to HRSR's ROE of +65.69%. Regarding short-term risk, NUVI is more volatile compared to HRSR. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check HRSR's competition here
NUVI vs NUUU Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, NUUU has a market cap of 117.8K. Regarding current trading prices, NUVI is priced at $4.00, while NUUU trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas NUUU's P/E ratio is -0.01. In terms of profitability, NUVI's ROE is +0.01%, compared to NUUU's ROE of +0.36%. Regarding short-term risk, NUVI is more volatile compared to NUUU. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check NUUU's competition here
NUVI vs EESO Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, EESO has a market cap of 72.9K. Regarding current trading prices, NUVI is priced at $4.00, while EESO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas EESO's P/E ratio is N/A. In terms of profitability, NUVI's ROE is +0.01%, compared to EESO's ROE of N/A. Regarding short-term risk, NUVI is more volatile compared to EESO. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check EESO's competition here
NUVI vs TVOG Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, TVOG has a market cap of 63.9K. Regarding current trading prices, NUVI is priced at $4.00, while TVOG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas TVOG's P/E ratio is -0.03. In terms of profitability, NUVI's ROE is +0.01%, compared to TVOG's ROE of +0.78%. Regarding short-term risk, NUVI is more volatile compared to TVOG. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check TVOG's competition here
NUVI vs EOSS Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, EOSS has a market cap of 60.5K. Regarding current trading prices, NUVI is priced at $4.00, while EOSS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas EOSS's P/E ratio is -0.01. In terms of profitability, NUVI's ROE is +0.01%, compared to EOSS's ROE of +0.64%. Regarding short-term risk, NUVI is more volatile compared to EOSS. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check EOSS's competition here
NUVI vs WNBD Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, WNBD has a market cap of 44.7K. Regarding current trading prices, NUVI is priced at $4.00, while WNBD trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas WNBD's P/E ratio is -0.04. In terms of profitability, NUVI's ROE is +0.01%, compared to WNBD's ROE of +0.01%. Regarding short-term risk, NUVI is more volatile compared to WNBD. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check WNBD's competition here
NUVI vs QNTA Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, QNTA has a market cap of 40.7K. Regarding current trading prices, NUVI is priced at $4.00, while QNTA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas QNTA's P/E ratio is 0.01. In terms of profitability, NUVI's ROE is +0.01%, compared to QNTA's ROE of +2.75%. Regarding short-term risk, NUVI is more volatile compared to QNTA. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check QNTA's competition here
NUVI vs GRBG Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, GRBG has a market cap of 39K. Regarding current trading prices, NUVI is priced at $4.00, while GRBG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas GRBG's P/E ratio is 0.10. In terms of profitability, NUVI's ROE is +0.01%, compared to GRBG's ROE of N/A. Regarding short-term risk, NUVI is more volatile compared to GRBG. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check GRBG's competition here
NUVI vs JOEY Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, JOEY has a market cap of 37.7K. Regarding current trading prices, NUVI is priced at $4.00, while JOEY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas JOEY's P/E ratio is 0.01. In terms of profitability, NUVI's ROE is +0.01%, compared to JOEY's ROE of +0.19%. Regarding short-term risk, NUVI is more volatile compared to JOEY. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check JOEY's competition here
NUVI vs EMPO Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, EMPO has a market cap of 25.1K. Regarding current trading prices, NUVI is priced at $4.00, while EMPO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas EMPO's P/E ratio is N/A. In terms of profitability, NUVI's ROE is +0.01%, compared to EMPO's ROE of -0.37%. Regarding short-term risk, NUVI is more volatile compared to EMPO. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check EMPO's competition here
NUVI vs HPTN Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, HPTN has a market cap of 22.7K. Regarding current trading prices, NUVI is priced at $4.00, while HPTN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas HPTN's P/E ratio is -0.04. In terms of profitability, NUVI's ROE is +0.01%, compared to HPTN's ROE of -1.08%. Regarding short-term risk, NUVI is more volatile compared to HPTN. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check HPTN's competition here
NUVI vs INBI Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, INBI has a market cap of 18.1K. Regarding current trading prices, NUVI is priced at $4.00, while INBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas INBI's P/E ratio is N/A. In terms of profitability, NUVI's ROE is +0.01%, compared to INBI's ROE of +0.54%. Regarding short-term risk, NUVI is more volatile compared to INBI. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check INBI's competition here
NUVI vs SYHO Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, SYHO has a market cap of 15.8K. Regarding current trading prices, NUVI is priced at $4.00, while SYHO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas SYHO's P/E ratio is N/A. In terms of profitability, NUVI's ROE is +0.01%, compared to SYHO's ROE of N/A. Regarding short-term risk, NUVI is more volatile compared to SYHO. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check SYHO's competition here
NUVI vs GYSN Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, GYSN has a market cap of 14K. Regarding current trading prices, NUVI is priced at $4.00, while GYSN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas GYSN's P/E ratio is N/A. In terms of profitability, NUVI's ROE is +0.01%, compared to GYSN's ROE of +0.14%. Regarding short-term risk, NUVI is more volatile compared to GYSN. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check GYSN's competition here
NUVI vs KPOC Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, KPOC has a market cap of 13.7K. Regarding current trading prices, NUVI is priced at $4.00, while KPOC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas KPOC's P/E ratio is N/A. In terms of profitability, NUVI's ROE is +0.01%, compared to KPOC's ROE of +0.01%. Regarding short-term risk, NUVI is more volatile compared to KPOC. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check KPOC's competition here
NUVI vs BRSHF Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, BRSHF has a market cap of 13.4K. Regarding current trading prices, NUVI is priced at $4.00, while BRSHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas BRSHF's P/E ratio is N/A. In terms of profitability, NUVI's ROE is +0.01%, compared to BRSHF's ROE of +14.14%. Regarding short-term risk, NUVI is more volatile compared to BRSHF. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check BRSHF's competition here
NUVI vs ZRVT Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, ZRVT has a market cap of 13K. Regarding current trading prices, NUVI is priced at $4.00, while ZRVT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas ZRVT's P/E ratio is -0.02. In terms of profitability, NUVI's ROE is +0.01%, compared to ZRVT's ROE of +0.04%. Regarding short-term risk, NUVI is more volatile compared to ZRVT. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check ZRVT's competition here
NUVI vs BEUT Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, BEUT has a market cap of 3.2K. Regarding current trading prices, NUVI is priced at $4.00, while BEUT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas BEUT's P/E ratio is N/A. In terms of profitability, NUVI's ROE is +0.01%, compared to BEUT's ROE of +1.96%. Regarding short-term risk, NUVI is more volatile compared to BEUT. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check BEUT's competition here
NUVI vs MDAV Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, MDAV has a market cap of 2.8K. Regarding current trading prices, NUVI is priced at $4.00, while MDAV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas MDAV's P/E ratio is N/A. In terms of profitability, NUVI's ROE is +0.01%, compared to MDAV's ROE of -1.64%. Regarding short-term risk, NUVI is more volatile compared to MDAV. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check MDAV's competition here
NUVI vs NCDP Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, NCDP has a market cap of 1.8K. Regarding current trading prices, NUVI is priced at $4.00, while NCDP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas NCDP's P/E ratio is N/A. In terms of profitability, NUVI's ROE is +0.01%, compared to NCDP's ROE of N/A. Regarding short-term risk, NUVI is more volatile compared to NCDP. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check NCDP's competition here
NUVI vs RBCL Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, RBCL has a market cap of 1.5K. Regarding current trading prices, NUVI is priced at $4.00, while RBCL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas RBCL's P/E ratio is -0.03. In terms of profitability, NUVI's ROE is +0.01%, compared to RBCL's ROE of -0.10%. Regarding short-term risk, NUVI is more volatile compared to RBCL. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check RBCL's competition here
NUVI vs PCGR Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, PCGR has a market cap of 785. Regarding current trading prices, NUVI is priced at $4.00, while PCGR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas PCGR's P/E ratio is -0.01. In terms of profitability, NUVI's ROE is +0.01%, compared to PCGR's ROE of -0.18%. Regarding short-term risk, NUVI is more volatile compared to PCGR. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check PCGR's competition here
NUVI vs SOYO Comparison June 2026
NUVI plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NUVI stands at 1.8M. In comparison, SOYO has a market cap of 617. Regarding current trading prices, NUVI is priced at $4.00, while SOYO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NUVI currently has a P/E ratio of 33.33, whereas SOYO's P/E ratio is 0.01. In terms of profitability, NUVI's ROE is +0.01%, compared to SOYO's ROE of N/A. Regarding short-term risk, NUVI is more volatile compared to SOYO. This indicates potentially higher risk in terms of short-term price fluctuations for NUVI.Check SOYO's competition here